Morning: Therapy of SLE: traditional drugs and new prospective
R. Danesi. The role of pharmacogenomics in the treatment of SLE
H. Bijlsma Corticosteroids and SLE
N. Costedoat- Chalumeau Hydroxychloroquine and SLE
F. Houssiau “Traditional drugs” in SLE. Focus on immunosuppressive drugs
R. Van Vollenhoven Biological therapies in SLE
A. Tyndall Stem cell therapy of SLE
Afternoon
A.G. Tzioufas Drug therapy and prevention of infertility in SLE
M. Mazzantini Drug therapy and osteoporosis in SLE
M. Ostensen Drug therapy and toxicity in pregnancy and lactation
Practice exercise: presentation of a computerized programme to assess and monitor SLE patients
Morning: Kidney involvement
Difficult clinical case: lupus nephritis
O. Rekvig Pathogenetic autoantibodies in lupus nephritis
P. Migliorini Laboratory assessment in lupus nephritis in routine clinical practice: a critical overview
G. Moroni Clinical features and prognostic factors in LN
to be defined Urinary proteomic in SLE
J. Berden Renal replacement therapy in SLE
D. Boumpas Therapeutic algorhytms in lupus nephritis
Presentation of 1 difficult clinical case
Afternoon: The challenging aspects of lupus
A. Delle Sedie Joint involvement in SLE
C.M. Montecucco Fever and SLE
R. Voll Hematological manifestations of SLE
G. Valesini Vaccines in SLE
P.C. Sarzi-Puttini Fybromyalgia and SLE
M. Schneider Late onset SLE
Presentation of 2 difficult clinical cases
Morning
Y. Shoenfeld Infections and autoimmunity
CNS involvement
Difficult clinical case
G. Riemekasten Pathogenesis of CNS involvement in SLE
A. Tincani Neurological manifestations of CNS involvement in SLE
M. Govoni Imaging and NPSLE
T. Huizinga Treatment of NPSLE
PRACTICAL POINT: The development of a questionnaire to assess neurological involvement in SLE patients
Afternoon : FREE
Morning
M. Ward Disease activity and damage indices in SLE, an overview
M. Mosca Recommendation for monitoring SLE patients in clinical practice
D. Boumpas EULAR Recommendations for the management of SLE
D. D’Cruz Fatigue and quality of life in SLE
R. Cervera Can we further improve SLE prognosis?
Afternoon: Skin involvement
Difficult clinical case: cutaneous involvement
V. Werth Overview of cutaneous manifestations in Lupus erythematosus
R. Rondinone Diagnosis and differential diagnosis of cutaneous involvement in Lupus Erythematosus
A. Kuhn: Treatment of cutaneous manifestations of Lupus Erythematosus
Presentation of 2 difficult clinical cases
Morning: SLE and related conditions
Clinical case: difficult to diagnose patient: SLE vs MCTD vs overlap syndrome
A. Doria Long-term prognosis in SLE patients
S. Bombardieri Undifferentiated connective tissue diseases
M. Aringer Overlap syndromes and MCTD
P.L. Meroni Anti-phospholipid syndrome
Presentation of 2 difficult clinical cases
Afternoon:Pregnancy and SLE
A. Martini Juvenile lupus
F. Strigini pregnancy in SLE: the obstetrician view
A. Brucato Neonatal lupus and outcome of babies of SLE patients
Presentation of 2 difficult clinical cases